Home
>
National Drug Code (NDC)
>
Triamterene and Hydrochlorothiazide
Triamterene and Hydrochlorothiazide - 55289-725-30 - (Triamterene and Hydrochlorothiazide)
Drug Information of Triamterene and Hydrochlorothiazide
| Product NDC: | 55289-725 |
| Proprietary Name: | Triamterene and Hydrochlorothiazide |
| Non Proprietary Name: | Triamterene and Hydrochlorothiazide |
| Active Ingredient(s): | 25; 50 mg/1; mg/1 & nbsp; Triamterene and Hydrochlorothiazide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Triamterene and Hydrochlorothiazide
| Product NDC: | 55289-725 |
| Labeler Name: | PD-Rx Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA073191 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19910731 |
Package Information of Triamterene and Hydrochlorothiazide
| Package NDC: | 55289-725-30 |
| Package Description: | 30 CAPSULE in 1 BOTTLE, PLASTIC (55289-725-30) |
NDC Information of Triamterene and Hydrochlorothiazide
| NDC Code | 55289-725-30 |
| Proprietary Name | Triamterene and Hydrochlorothiazide |
| Package Description | 30 CAPSULE in 1 BOTTLE, PLASTIC (55289-725-30) |
| Product NDC | 55289-725 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Triamterene and Hydrochlorothiazide |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 19910731 |
| Marketing Category Name | ANDA |
| Labeler Name | PD-Rx Pharmaceuticals, Inc. |
| Substance Name | HYDROCHLOROTHIAZIDE; TRIAMTERENE |
| Strength Number | 25; 50 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Decreased Renal K+ Excretion [PE],Increased Diuresis [PE],Potassium-sparing Diuretic [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
